Published on
Mar 13, 2025
The Role of Radiosensitizing Drugs in Osteosarcoma Treatment: Mechanisms and Clinical Perspectives
Introduction Osteosarcoma is the most common primary malignant tumor, with the total number of cases accounting for approximately 35% of all cases of primary malignant tumors.1,2 Moreover, patients with incompletely resectable or recurrent osteosarcoma …
Source:
Dove Medical Press
-
Neutral
